March 22-23, 2025

Available DatesRegister Now

Saturday March 22, 2025

  • 8:00 AM – 9:00 AM

    Non-CME Innovation Theater

  • 9:05 AM – 9:10 AM

    Welcome

  • 9:10 AM – 9:55 AM

    Diagnostic Biomarkers Testing/Liquid Biopsies

    • Presenter
      • Andrew McKenziePhD
    • Room:
      • Astor Ballroom
  • 10:05 AM – 10:35 AM

    Navigating the Evolving Treatment Landscape for EGFR-Mutated Non-Small Cell Lung Cancer

    • Room:
      • Gramercy/Herald
  • 10:05 AM – 10:35 AM

    Selected Topic in Gastrointestinal Cancers

    • Room:
      • Astor Ballroom
  • 10:05 AM – 10:35 AM

    Selected Topic in Women's Cancers

    • Room:
      • Chelsea/Hudson
  • +
    10:35 AM – 11:20 AM

    Debate: CTLA-4 Inhibition in Lung Cancer: The Time is Now or Never? Now vs Never

    • Moderator
      • Corey LangerMD, FACP
      • Edward GaronMD, MS
    • Speaker
      • Estelamari Rodriguez
      • Shirish GadgeelMD
    • Room:
      • Gramercy/Herald
    • 10:35 AM – 10:55 AM
      CTLA-4 Inhibition in Lung Cancer: The Time is Now or Never? Now
    • 10:55 AM – 11:15 AM
      CTLA-4 Inhibition in Lung Cancer: The Time is Now or Never? Never
  • +
    10:35 AM – 11:20 AM

    Debate: Antibody Drug Conjugates: Should We Use Sequentially? Yes, They Are Better than Chemo vs No, the Benefit is Really Just for the First ADC

    • Moderator
      • Kelly McCannMD, PhD
      • Erika HamiltonMD
    • Room:
      • Chelsea/Hudson
    • 10:35 AM – 10:55 AM
      Antibody Drug Conjugates: Should We Use Sequentially? Yes, They Are Better than Chemo
    • 10:55 AM – 11:15 AM
      Antibody Drug Conjugates: Should We Use Sequentially? No, the Benefit is Really Just for the First ADC
  • +
    10:35 AM – 11:20 AM

    Debate: State-of-the-Art Management of Localized GEJ Cancer: Neoadjuvant vs. Adjuvant Therapy

    • Moderator
      • Cathy EngMD, FACP, FASCO
      • Yelena JanjigianMD
    • Speaker
      • Nataliya UbohaMD, PhD
      • Samuel CytrynMD
    • Room:
      • Astor Ballroom
    • 10:35 AM – 10:55 AM
      State-of-the-Art Management of Localized GEJ Cancer: Adjuvant Therapy
    • 10:55 AM – 11:15 AM
      State-of-the-Art Management of Localized GEJ Cancer: Neoadjuvant Therapy
  • 11:20 AM – 12:05 PM

    Exhibit Hall